An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes

JOURNAL ARTICLE published 2014 in Leukemia Research Reports

Authors: Stuart L. Goldberg | Pierre Fenaux | Michael D. Craig | Emmanuel Gyan | John Lister | Jeannine Kassis | Arnaud Pigneux | Gary J. Schiller | JungAh Jung | E. Jane Leonard | Howard Fingert | Peter Westervelt